For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los ...

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...

Contributor Content In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.

The blood-brain barrier is a network of blood vessels and tissues that acts as a protective shield, preventing harmful substances in the blood from reaching the brain. In Alzheimer’s disease, this ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the ...